
May 21, 2026
Revvity stock (US76155R1086): life science player after Q1 update and new AI lab tools
Revvity has recently provided its Q1 2026 financial update, showcasing its commitment to expanding its portfolio of life science tools, particularly through the integration of AI technologies in lab software.In its latest earnings report, Revvity emphasized ongoing investments in diagnostics and life science tools, highlighting advancements in AI-supported lab solutions. The company aims to enhance its offerings in molecular diagnostics and research tools, positioning itself as a significant pla


